Other: nbt-nm108 (0 g/day) (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04574024 (ClinicalTrials.gov) | January 11, 2021 | 21/9/2020 | HFP (High-Fiber Supplement) in MS (Multiple Sclerosis) | Effect of High-fiber Supplement in Multiple Sclerosis | Multiple Sclerosis | Drug: NBT-NM108 (60 g/day);Other: NBT-NM108 (0 g/day) | Suhayl Dhib-Jalbut, MD | NULL | Not yet recruiting | 21 Years | 55 Years | All | 50 | Phase 1;Phase 2 | United States |